Are we meeting the American Diabetes Association goals for HIV-infected patients with diabetes mellitus?
We determined rates of achieving the American Diabetes Association goals among human immunodeficiency virus (HIV)-infected diabetic patients. American Diabetes Association goals (for hemoglobin A1c, blood pressure, and lipid levels) were defined by 2008 American Diabetes Association guidelines. HIV-infected diabetic patients achieved American Diabetes Association goals at rates similar to those in general medicine clinic patients. A multidisciplinary approach is needed to improve diabetes management in HIV clinics.
Adeyemi
Oluwatoyin
O
CORE Center, John H. Stroger, Jr. Hospital of Cook County and Rush University Medical Center, Chicago, Illinois, USA. Oluwatoyin_adeyemi@rush.edu
Vibhakar
Sonia
S
Max
Blake
B
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D044966:Anti-Retroviral Agents / Q000009:adverse effects / Q000627:therapeutic use; D001794:Blood Pressure; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications* / Q000628:therapy*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis*; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D017410:Practice Guidelines as Topic; D011320:Primary Health Care / Q000592:standards* / Q000706:statistics & numerical data; D012189:Retrospective Studies; D012955:Societies, Medical; D014481:United States
D019380:Anti-HIV Agents; D044966:Anti-Retroviral Agents; D006442:Glycated Hemoglobin; D008055:Lipids